Article Text

other Versions

PDF
Is gastric cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? - A molecular genetic study
  1. Annette Gylling (annette.lindroos{at}helsinki.fi)
  1. Department of Medical Genetics, University of Helsinki, Finland
    1. Wael M Abdel-Rahman (wael.abdel-rahman{at}helsinki.fi)
    1. Department of Medical Genetics, University of Helsinki, Finland
      1. Matti Juhola (matti.juhola{at}ksshp.fi)
      1. Department of Pathology, Jyväskylä Central Hospital, Finland
        1. Kyösti Nuorva (kyosti.nuorva{at}ksshp.fi)
        1. Department of Pathology, Jyväskylä Central Hospital, Finland
          1. Emmi Hautala (emmi.hautala{at}helsinki.fi)
          1. Department of Medical Genetics, University of Helsinki, Finland
            1. Heikki J Järvinen (heikki.jarvinen{at}hus.fi)
            1. Helsinki University Central Hospital, Finland
              1. Jukka-Pekka Mecklin (jukka-pekka.mecklin{at}ksshp.fi)
              1. Department of Surgery, Jyvaskyla Central Hospital, Finland
                1. Markku Aarnio (markku.aarnio{at}ksshp.fi)
                1. Department of Surgery, Jyvaskyla Central Hospital, Finland
                  1. Päivi Peltomäki (paivi.peltomaki{at}helsinki.fi)
                  1. Department of Medical Genetics, University of Helsinki, Finland

                    Abstract

                    Background and aims: Gastric cancer is the second most common extracolonic malignancy in individuals with hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome. Since gastric cancer is relatively common in the general population as well it is unsettled whether or not gastric cancer is a true HNPCC spectrum malignancy.

                    Subjects and methods: To this end, the molecular and clinicopathological profiles of gastric cancers (N=13) from HNPCC mutation carriers were evaluated and compared to sporadic gastric cancers (N=46) stratified by histology and microsatellite instability (MSI) status.

                    Results: Our study on sporadic and HNPCC gastric cancers revealed several important universal associations. Loss of heterozygosity in the APC region was associated with intestinal histology regardless of MSI (P=0.0070). KRAS mutations (P=0.019) and frameshift mutations in repeat tracts of growth-regulatory genes (P<0.0001) were associated with MSI tumors being absent in MSS tumors. The average number of methylated tumor suppressor gene loci among 24 genes studied (methylation index) was higher in MSI vs. microsatellite-stable (MSS) tumors regardless of histology (P<0.0001). Gastric cancers from HNPCC mutation carriers resembled sporadic intestinal MSI gastric cancers, except that MLH1 promoter methylation was absent (P=0.00049) and the general methylation index lower (P=0.038), suggesting similar but not identical developmental pathways. All lacked the mismatch repair protein corresponding to the germline mutation and displayed MSI-high.

                    Conclusion: The present molecular evidence combined with the previous demonstration of increased incidence relative to the general population make it justified to consider gastric cancers as true HNPCC spectrum malignancies.

                    • Hereditary nonpolyposis colorectal cancer
                    • gastric cancer
                    • methylation
                    • microsatellite instability

                    Statistics from Altmetric.com

                    Request permissions

                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                    Linked Articles

                    • Digest
                      BMJ Publishing Group Ltd and British Society of Gastroenterology